
|Articles|June 1, 2016
- Pharmaceutical Executive-06-01-2016
- Volume 36
- Issue 6
Pharmaceutical Executive, June 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Pharm Exec's Top 50 Companies 2016almost 10 years ago
Diversity and Inclusion: A Pharma 50 Perspectivealmost 10 years ago
Market Access in Europe: Building Health Equity Through Better Outcomesalmost 10 years ago
Design that Deliversalmost 10 years ago
A Digital Prescription for the Pharma Industryalmost 10 years ago
Science Meets Art: Mapping the Topography of MSalmost 10 years ago
Pharma and Biotech Financial Outlook: Hazyalmost 10 years ago
Promises and Pitfalls in Calculating Drug Valuealmost 10 years ago
Europe’s ‘Radical’ Regulators Drawn Further into Pricing Debatealmost 10 years ago
Country Report: ItalyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
4
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
5




